These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 25615529)

  • 1. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
    Huang L; Liu X; Cheng B; Huang K
    Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of water in protein folding, oligomerization, amyloidosis and miniprotein.
    Vajda T; Perczel A
    J Pept Sci; 2014 Oct; 20(10):747-59. PubMed ID: 25098401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of protein structure instability: from physiological to pathological secondary structure.
    Sukhanova A; Poly S; Shemetov A; Bronstein I; Nabiev I
    Biopolymers; 2012 Aug; 97(8):577-88. PubMed ID: 22605549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
    Nerelius C; Fitzen M; Johansson J
    Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diethylpyrocarbonate modification reveals HisB5 as an important modulator of insulin amyloid formation.
    Yang X; Li Y; Huang L; Zhang X; Cheng C; Gong H; Ma L; Huang K
    J Biochem; 2015 Jan; 157(1):45-51. PubMed ID: 25172962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies.
    Salahuddin P; Khan RH; Furkan M; Uversky VN; Islam Z; Fatima MT
    Int J Biol Macromol; 2021 Sep; 186():580-590. PubMed ID: 34271045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics simulations of amyloid fibrils: an in silico approach.
    Ye W; Wang W; Jiang C; Yu Q; Chen H
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):503-8. PubMed ID: 23532062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
    Foguel D; Silva JL
    Biochemistry; 2004 Sep; 43(36):11361-70. PubMed ID: 15350123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaperone-like Activity of Calnuc Prevents Amyloid Aggregation.
    Kanuru M; Aradhyam GK
    Biochemistry; 2017 Jan; 56(1):149-159. PubMed ID: 27997158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Starting at the beginning: endoplasmic reticulum proteostasis and systemic amyloid disease.
    Romine IC; Wiseman RL
    Biochem J; 2020 May; 477(9):1721-1732. PubMed ID: 32412081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amyloid interactome: Exploring protein aggregation.
    Biza KV; Nastou KC; Tsiolaki PL; Mastrokalou CV; Hamodrakas SJ; Iconomidou VA
    PLoS One; 2017; 12(3):e0173163. PubMed ID: 28249044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into amyloid-like aggregation of H2 region of the C-terminal domain of nucleophosmin.
    Russo A; Diaferia C; La Manna S; Giannini C; Sibillano T; Accardo A; Morelli G; Novellino E; Marasco D
    Biochim Biophys Acta Proteins Proteom; 2017 Feb; 1865(2):176-185. PubMed ID: 27865970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Amyloid Drug Screening Methods Using Bacterial Inclusion Bodies.
    Caballero AB; Gamez P; Sabate R; Espargaró A
    Methods Mol Biol; 2022; 2538():165-188. PubMed ID: 35951300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration.
    Rozemuller AJ; Jansen C; Carrano A; van Haastert ES; Hondius D; van der Vies SM; Hoozemans JJ
    Neurodegener Dis; 2012; 10(1-4):301-4. PubMed ID: 22398730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
    Horvath I; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12473-12477. PubMed ID: 27791129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring critical determinants of protein amyloidogenesis: a review.
    Sarkar N; Dubey VK
    J Pept Sci; 2013 Sep; 19(9):529-36. PubMed ID: 23873708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.
    Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K
    Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins.
    Munishkina LA; Fink AL
    Biochim Biophys Acta; 2007 Aug; 1768(8):1862-85. PubMed ID: 17493579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.